|
MXPA06001002A
(es)
*
|
2003-07-25 |
2006-04-11 |
Amgen Inc |
Piridonas y pirimidinonas sustituidas con propiedades antiinflamatorias.
|
|
EP1656366A1
(en)
*
|
2003-08-20 |
2006-05-17 |
Amgen Inc. |
Substituted pyrimdinone derivatives and methods of use
|
|
NZ556017A
(en)
*
|
2004-12-24 |
2009-10-30 |
Prosidion Ltd |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US8062824B2
(en)
|
2006-07-17 |
2011-11-22 |
E. I. Du Pont De Nemours And Company |
Thermally imageable dielectric layers, thermal transfer donors and receivers
|
|
US7528448B2
(en)
*
|
2006-07-17 |
2009-05-05 |
E.I. Du Pont De Nemours And Company |
Thin film transistor comprising novel conductor and dielectric compositions
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
SI2203439T1
(sl)
|
2007-09-14 |
2011-05-31 |
Ortho Mcneil Janssen Pharm |
1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
|
|
US7666568B2
(en)
*
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Composition and method for providing a patterned metal layer having high conductivity
|
|
US7666567B2
(en)
|
2007-10-23 |
2010-02-23 |
E. I. Du Pont De Nemours And Company |
Negative imaging method for providing a patterned metal layer having high conductivity
|
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
JP5690277B2
(ja)
|
2008-11-28 |
2015-03-25 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN102439008B
(zh)
|
2009-05-12 |
2015-04-29 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
|
|
BRPI1010831A2
(pt)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
|
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
US9271967B2
(en)
|
2010-11-08 |
2016-03-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
EP2681215B1
(en)
|
2011-02-28 |
2015-04-22 |
Array Biopharma, Inc. |
Serine/threonine kinase inhibitors
|
|
US9187462B2
(en)
|
2011-08-04 |
2015-11-17 |
Array Biopharma Inc. |
Substituted quinazolines as serine/threonine kinase inhibitors
|
|
US9221809B2
(en)
|
2011-10-31 |
2015-12-29 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
US10531655B2
(en)
|
2011-12-02 |
2020-01-14 |
The Regents Of The University Of California |
Reperfusion protection solution and uses thereof
|
|
DK2820009T3
(en)
*
|
2012-03-01 |
2018-04-16 |
Array Biopharma Inc |
Serine / threonine kinase inhibitors
|
|
TW201408658A
(zh)
|
2012-08-27 |
2014-03-01 |
Array Biopharma Inc |
絲胺酸／酥胺酸激酶抑制劑
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
MX386697B
(es)
|
2014-01-21 |
2025-03-19 |
Janssen Pharmaceutica Nv |
Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
|
|
BR112019021388B1
(pt)
*
|
2017-04-11 |
2023-10-31 |
Mitsui Chemicals Crop & Life Solutions, Inc |
Compostos, agente de controle de pragas agrícolas e hortícolas, fungicida agrícola e hortícola e métodos para prevenção e/ou tratamento de uma doença de plantas
|
|
TW202325302A
(zh)
*
|
2017-08-23 |
2023-07-01 |
瑞典商斯普林特生物科技公司 |
吡啶胺-吡啶酮及嘧啶胺-吡啶酮化合物
|
|
JP7199737B2
(ja)
*
|
2017-08-23 |
2023-01-06 |
スプリント バイオサイエンス アクティエボラーグ |
ピリジルピリドン化合物
|
|
US12479816B2
(en)
|
2019-02-08 |
2025-11-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
20-HETE formation inhibitors
|
|
US11801238B2
(en)
|
2020-11-25 |
2023-10-31 |
Deciphera Pharmaceuticals, Llc |
Anti-viral activity of VPS34 inhibitors
|
|
IL314895A
(en)
*
|
2022-02-16 |
2024-10-01 |
Duke Street Bio Ltd |
Pharmaceutical compound
|
|
EP4626878A1
(en)
|
2022-12-02 |
2025-10-08 |
Neumora Therapeutics, Inc. |
Methods of treating neurological disorders
|